top of page

Highlights from the Valentine Conclave

 LECTURES

1

Treating HF in 2025: lessons from the ESC guidelines

2

Hypertension in Heart Failure – Optimizing antihypertensive therapy in HF: Practical considerations OR BP control in HFrEF vs. HFpEF: different priorities

3

Targeting heart rate in patients with heart failure

4

Optimizing outcomes in heart failure with valvular heart disease

5

Address the etiology: implementing lipid-lowering strategies in patients with ischemic heart failure

 SESSIONS

1

GDMT uptake in real-world heart failure

  • The sizes of the problem: Status of GDMT implementation worldwide

  • Strategies for GDMT implementation: Targeting the physician and the healthcare system

  • ​Adherence: A therapeutic target in heart failure?

2

Advances in Heart Failure: A 2025 Update

  • DIGIT-HF

  • DAPA-ACT HF-TIMI 68

  • VICTOR & VICTORIA+VICTOR pooled analysis

3

Decoding HFpEF: Which therapeutic implications?

  • HFpEF: One disease or many faces?

  • Obesity: A therapeutic target in HF?

  • MRA in HFpEF: Steroidal or non-steroidal?

4

Treating cardiomyopathies in 2025

  • Hypertrophic cardiomyopathy

  • Cardiac amyloidosis

© Valentine Conclave, All Rights Reserved by Valentine Conclave.

bottom of page